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Abstract
Background: There are few existing large population studies on the epidemiology of metabolic
syndrome-related disorders of Turkey. The purpose of this study was to assess the prevalence of
metabolic syndrome-related disorders in the Turkish adult population, to address sex, age,
educational and geographical differences, and to examine blood pressure, body mass index, fasting
blood glucose and serum lipids in Turkey.
Methods: This study was executed under the population study "The Healthy Nutrition for Healthy
Heart Study" conducted between December 2000 and December 2002 by the Health Ministry of
Turkey. Overall, 15,468 Caucasian inhabitants aged over 30 were recruited in 14 centers in the
seven main different regions of Turkey. The data were analyzed with the Students' t, ANOVA or
Chi-Square tests.
Results: Overall, more than one-third (35.08 %) of the participants was obese. The hypertensive
people ratio in the population was 13.66 %, while these ratios for DM and metabolic syndrome
were 4.16 % and 17.91 %, respectively. The prevalence of hypertension, metabolic syndrome and
obesity were higher in females than males, whereas diabetes mellitus was higher in males than
females. The prevalence of metabolic syndrome and related disorders were found to be significantly
different across educational attainments for both men and women. The prevalence of hypertension
increased with age, while it was remarkable that in the age group of 60–69 years, prevalence of
diabetes mellitus and metabolic syndrome reached a peak value and than decreased. For obesity,
the peak prevalence occurred in the 50–59 year old group. The prevalence of metabolic syndrome
and related disorders were found to be significantly different according to geographical region.
Conclusion: In conclusion, high prevalence of obesity and metabolic syndrome, particularly among
women, is one of the major public health problems in Turkey. Interestingly, obesity prevalence is
relatively high, but the prevalence of hypertension and hypercholesterolemia is relatively low in
Turkish people. Future studies may focus on elucidating the reasons behind this controversy. Our
findings may be helpful in formulating public health policy and prevention strategies on future health
in Turkey.
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Background
Turkey, with its large land area, more than 70 million peo-
ple, and growing economy, resembles a bridge in geo-
graphical aspects between Europe and Asia. There are few
existing large population studies on the epidemiology of
metabolic syndrome-related disorders of Turkey. Turkish
Adults Risk Factor Study (TEKHARF) was the first study,
representing the whole country, conducted by the Turkish
Cardiology Association [1].
The etiology, prevention, and treatment of the metabolic
syndrome currently are the focus of the intense research
activities. The combination of abdominal obesity, hyper-
tension, dyslipidemia, hyperglycemia, and insulin resist-
ance or type 2 diabetes mellitus defines the metabolic
syndrome [2]. The metabolic syndrome is said to consist
of a cluster of metabolic risk factors, including dyslipi-
demia, impaired carbohydrate metabolism, obesity, and
high blood pressure [3,4]. In 1999, the WHO published
the first official definition of the metabolic syndrome [5].
The new IDF definition of the metabolic syndrome
addresses both clinical and research needs and provides
an accessible, diagnostic tool that is suitable for use in
populations worldwide [6]. The pathogenesis of meta-
bolic syndrome is still unclear, although some environ-
mental factors, coupled with still largely unknown genetic
factors, clearly interact to produce the syndrome [7,8].
Previous reports using population-based data from the
Third National Health and Nutrition Examination Survey
have estimated the age-adjusted prevalence of metabolic
syndrome to be 21.8% among adults in the United States
[9-11].
The purpose of this study was to assess the prevalence of
the metabolic syndrome-related disorders in the Turkish
adult population of more than 15,000 persons, to address
sex, age, educational and geographical differences, and to
examine blood pressure, BMI, fasting blood glucose and
serum lipids in Turkey.
Methods
This study was executed under the population study "The
Healthy Nutrition for Healthy Heart Study" conducted
between December 2000 and December 2002 by the
Health Ministry of Turkey. Overall, 15,468 Caucasian
inhabitants aged over 30 were recruited in 14 centers in
the seven main different regions of Turkey that would rep-
resent whole Turkish People in terms of living conditions
and geographic background (Figure 1). Marmara, Aegean
and Mediterranean regions are in the western part of Tur-
key, while Eastern and South-Eastern Anatolia are in the
eastern part. Black Sea region is in the northern side. The
number of people for each center was calculated by using
stratified sampling technique. In the selection of the par-
ticipants, we used random number table. In order to cover
the whole population of Turkey, men and women were
randomly selected from urban and rural areas from all
regions. Sample size for the study was calculated by allow-
ing for 0.25% error in prevalence with 95% confidence
interval (CI). At the end of the study, we reached 15,468
Main Geographical Regions and Location of the Study Centers Figure 1
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people. The response rate was 87.3 %. Sample sizes for
each health center were calculated using the census of the
year 2000 by stratified sampling method [12]. Data form
was developed after the execution of a pilot study. All
socio-demographic data (age, gender, and educational
level), and medical history were obtained through a med-
ical staff by using a standardized questionnaire in the
study centers. Educational attainment was categorized as
illiterate, literate only, elementary education, high school
graduate or a university education. Completion of the
questionnaire was considered to imply informed consent.
The study was carried out in accordance with the guide-
lines of the Helsinki Declaration of Human Studies.
Study participants were studied in six separate age groups,
namely those aged 30–39, 40–49, 50–59, 60–69, 70–79
and those aged older than 80. The survey was representa-
tively stratified for sex, age, and for rural-urban distribu-
tion.
Seven measures representing the metabolic syndrome
were obtained, including fasting blood glucose, BMI,
HDL-C and Low-density lipoprotein cholesterol (LDL-C),
triglycerides, systolic blood pressure, and diastolic blood
pressure. At the baseline examination, blood samples
were taken after a minimum 6-hour fast. Serum was sepa-
rated on-site within 30 minutes of venipuncture, stored at
-4°C, and analyzed within 24 hours of venipuncture.
Determination of routine biochemical parameters was
performed with standard techniques by using an autoan-
alyser. Values for each person were calculated by Friede-
wald's formula and LDL-C values >10.36 mmol/l were not
taken into account.
Because waist circumference was not determined in this
study, we defined the metabolic syndrome using BMI (≥
30 kg/m2 for both men and women) instead of waist cir-
cumference. BMI was calculated as the ratio of body
weight to square of body height (kg/m2). Obesity was
defined based on BMI 30 kg/m2. Blood pressure was cal-
culated as the average of three measurements taken under
standardized conditions in a supine position with a
sphygmomanometer. Diabetes mellitus was defined as a
fasting blood glucose level = 7 mmol/l, or reported use of
diabetes medication. The IDF definition was used for the
diagnosis of the metabolic syndrome [6].
A total of data were analyzed by StatsDirect (Ver 2.2.0,
Stats Direct Ltd, UK) and SPSS 11.5 (SPSS Inc., Chicago,
Il., USA) software. Descriptives were shown either the per-
centages or mean ± SD for categorical and continuous var-
iables, respectively. In order to minimize the effects of the
outliers we calculated the 5% trimmed means. Parameters
of two group of people were compared by "Independent
samples t test". "Analysis of variance (ANOVA test)" was
used to compare the parameters of more than two groups.
Relations among the categorical parameters were investi-
gated by "Chi-square test". pvalues less than or equal to
0.05 were considered as statistically significant.
Results
A total of 2096 (13.6 %) were from Marmara, 1555 (10.1
%) were from Eastern Anatolia, 2541 (16.4 %) were from
Southeast Anatolia, 2554 (16.5 %) were from Mediterra-
nean, 2519 (16.3%) were from Aegean, 2190 (14.2 %)
were from Black Sea, and 2013 (13.0 %) were from Cen-
tral Anatolia.
Based on self-report, 20.3% were illiterate (n = 3123),
18.0 % were literate only (n = 2766), 41.2% of the people
(n = 6334) were elementary education, 13.1 % were high
school graduate (n = 2015), and 7.4% were university
educated (n = 1136).
Overall, more than one-third (35.08 %) of the partici-
pants was obese. The hypertensive people ratio in the pop-
ulation was 13.66 %, while these ratios for DM and
metabolic syndrome were 4.16 % and 27.38 %, respec-
tively.
The prevalence of hypertension, metabolic syndrome and
obesity were higher in females than males, whereas diabe-
tes mellitus was higher in males than females (Table 1).
There were no statistically significant difference between
the urban and rural areas with respect to metabolic syn-
drome and related disorders such as hypertension, diabe-
tes mellitus, and obesity (data not shown). The prevalence
of metabolic syndrome and related disorders were found
to be significantly different across educational attain-
ments for both men and women (Table 1). Obese men
and women tended to have lower educational attainment
(Table 1). The prevalence of hypertension increased with
age, while it was remarkable that in the age group of 60–
69 years, prevalence of diabetes mellitus and metabolic
syndrome reached a peak value and than decreased (Table
1). For obesity, the peak prevalence occurred in the 50–59
year old group. The prevalence of metabolic syndrome
and related disorders were found to be significantly differ-
ent according to geographical region (Table 1).
The distribution across regions of biochemical parameters
by geographical region, gender and age groups is pre-
sented in the Table 2 and 3. The differences of biochemi-
cal parameters among the geographical regions were
significantly different (Table 2), while they, except HDL-
C, were significantly different among the age groups
(Table 3). When the data compared according to gender,
we found that total cholesterol and LDL-C in the age
groups of 30–39, 50–59 and 60–69, total cholesterol andBMC Public Health 2006, 6:92 http://www.biomedcentral.com/1471-2458/6/92
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triglyceride in the 70–79 age group, and triglyceride in
40–49 age group were significantly different (Table 3).
Mean total cholesterol level of our study population was
4.92 mmol/l (4.91 mmol/l in men and 4.92 mmol/l in
women). Hypercholesterolemic levels were recorded in
29.89% in men, 28.35 in women in the present study.
Mean LDL-C level was 2.92 mmol/l (2.96 mmol/l in men,
2.90 mmol/l in women). High values of LDL-C were
found 29.89% in men and 28.35% in women in our
study. Mean concentrations of HDL-C, were 1.10 mmol/l
(1.10 mmol/l in men and women). In the current study,
lower HDL-C concentrations were found 25.16% in men
and 32.39% in women. In our study, mean concentra-
tions of triglyceride were 1.76 mmol/l (1.80 mmol/l in
men and 1.75 mmol/l in women). In addition, prevalence
of hypertriglyceridemia in our study was 35.54% (40.72%
in men and 33.23% in women).
Discussion
This study is one of the largest population-based studies
of metabolic syndrome-related disorders ever conducted
in Turkey. The prevalence of metabolic syndrome was
10.09 and 27.33 % in men and women, respectively. Onat
et al. reported a higher prevalence of the metabolic syn-
drome in Turkish adults (27% in men and 38.6% in
women) than our findings [13]. In the National Health
and Nutrition Examination Survey sample in U.S. adults
[11], age-adjusted prevalence of the metabolic syndrome
was 24.0% and 23.4% in men and women, respectively.
In the current study, the prevalence of diabetes was deter-
mined to be 4.16% (5.22% in men and 3.69% in
women). Onat et al. reported that prevalence of diabetes
in a Turkish population was 3.4% (4.2% for men and
2.8% for women) [13]. In The Turkish Diabetes Epidemi-
ology Study (TURDEP), the prevalence of diabetes was
7.4% (6.2% in men and 8.0% in women) [14]. On the
other hand, the overall prevalence of obesity was 35.08 %
(21.16% in men and 41.32% in women) in our study.
Similar to our results, in a large multicenter nationwide
study [1], this prevalence was found to be 25.3% for Turk-
ish males and 44.2% for Turkish females. Conversely, Sat-
man et al. reported that the low prevalence of obesity in
adults in Turkey was 22.3% (12.9% in men, 29.9% in
women) [14]. Finally, the prevalence of hypertension in
our study (13.66%) was relatively lower than a previous
study (46%) [15].
In the present study, there was a clear age-related increase
in the prevalence of the metabolic syndrome in Turkish
adult population. The prevalence of metabolic syndrome
was the lowest at age group 30–39 (15.34%), while it pro-
gressively increased with age until the age group 50–59
(27.98%). Ford et al. reported the prevalence of metabolic
syndrome increased with age, and 33–45% of subjects
over 50 years met the criteria for the metabolic syndrome
[11]. In this context, aging may be a risk factor for meta-
bolic syndrome. In many studies, it was also reported that
the prevalence of diabetes increased with age [16-20].
Likewise, in the current study, the prevalence of obesity
increased markedly from the 30- to 39-year-old age group
to the 50- to 59-year-old age group and then decreased. In
many studies, it has been reported that prevalence of
obesity increases with age [21-23]. This can be explained
partly by a decrease in the degree of physical activity by
aging [21,24].
The prevalence of diabetes, obesity, hypertension and
metabolic syndrome was found to be decreased with high
educational levels in our study. The results are in line with
studies conducted in Turkey and Europe [21,25-27,31]. In
a recent study [25], a clear association was reported
between education and blood glucose levels and a higher
risk of diabetes associated with lower levels of education.
It is known that unhealthy dietary habits as a high fat
intake and low fruit and vegetable intake, as well as phys-
ical inactivity, are inversely related with educational level
[32].
We found that the prevalence of diabetes among the
regions was the highest in South-East Anatolia region. A
study conducted by Gokcel et al. [20] in Adana, a city in
South-East Anatolia, reported the diabetes prevalence as
11.6%. On the contrary, as reported previously [33], the
lowest prevalence of diabetes was obtained from the par-
ticipants living in the Eastern Anatolia Region of Turkey.
In consistent with our observation, in Central Anatolia,
the prevalence of diabetes was reported as 6.4% [19] and
6.9% [34]. Similar to our results, the prevalence of diabe-
tes was 5.2% in Trabzon, a city located in the Black Sea
Region. On the other hand, in contrast to a previous
report [14], subjects living in the Eastern and South-East
Anatolia Region of Turkey had the highest prevalence of
obesity in our study. However, consistent with the same
report [14], obesity prevalence in Central Anatolia was
high. In the Black Sea Region, prevalence of obesity was
found to be higher (36.89%) than a previous study
(19.2%) [35]. The average values of total cholesterol, LDL-
C, and triglyceride were also higher in South-Eastern Ana-
tolia, Eastern Anatolia and Central Anatolia than the other
regions. Consumption of foods with high fat and sugar
content is also frequent in this area [36]. In our study, the
prevalence of obesity in Marmara Region is consistent
with a previous report [37] and this region has the lowest
obesity prevalence as well as Aegean region. This may be
due to participants from these regions consume more veg-
etables, less carbohydrate; prefer olive oil or corn oil more
when cooking [38,39]. The hypertension prevalence
among the geographical areas in Turkey is also considera-
bly different. Like a previous report [14], the prevalenceBMC Public Health 2006, 6:92 http://www.biomedcentral.com/1471-2458/6/92
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was lower in the western region (Mediterranean and
Aegean Regions) than the northern region (Black Sea
Region). Environmental factors or individual exposures
such as salt intake may cause such differences in preva-
lence among these populations.
In the current study, as in others [40,41], mean total cho-
lesterol, LDL-C and HDL-C level of Turkish adults was
lower than the Northern Europe and the Mediterranean
populations [42]. The mean concentrations of triglyceride
were higher than the Turkish Heart Study [43].
Conclusion
In conclusion, high prevalence of obesity and metabolic
syndrome, particularly among women, is one of the major
public health problems in Turkey. Interestingly, obesity
prevalence is relatively high, but the prevalence of hyper-
tension and hypercholesterolemia is relatively low in
Turkish people. Future studies may focus on elucidating
the reasons behind this controversy. Our findings may be
helpful in formulating public health policy and preven-
tion strategies on future health in Turkey.
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ing to the Age Groups and Gender (5% Trimmed Mean)
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